Anti-kit antibodies and uses thereof

Anti-GARP antibody

Monoclonal antibodies against IgV domain of B7-H3 and uses thereof

CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease

Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

Compounds specific to coronavirus S protein and uses thereof

IN VITRO PRODUCTION OF HIGH AFFINITY MONOCLONAL ANTIBODIES

BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

Agonistic anti TNFR2 antibody molecules

Anti-PD-L1/VEGF bifunctional antibody and use thereof

Anti-PD-L1 antibodies and methods of making and using thereof

Antibody Therapeutics that Bind CTLA4

Antibodies binding CTLA-4 and uses thereof

Humanized anti-PD-1 antibody and the use thereof

Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies

HOMODIMER-TYPE BISPECIFIC ANTIBODY TARGETING CD19 AND CD3, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Multi-specific antibodies and methods of making and using thereof

Nucleic acids encoding anti-TREM-1 antibodies

Anti-ILT4 antibodies and antigen-binding fragments

ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENT

Anti-plasmodium falciparum HRP-II antibody

Broadly Neutralizing Anti-HIV Antibodies and Epitope Therefor

Broadly-neutralizing anti-HIV antibodies

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

ANTI-TAQ DNA POLYMERASE ANTIBODY AND USE THEREOF

ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF

Bispecific antigen-binding constructs targeting HER2

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bind PSMA and CD3, and Uses Thereof

Transferrin receptor (TfR)-selective binding peptides capable of crossing the blood brain barrier and methods of use thereof

Anti-CD40 antibodies and uses thereof

Anti-colony stimulating factor 1 receptor (CSF1R) antibodies and methods of use thereof for treating cancer

WNT SIGNALING AGONIST MOLECULES

Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof

Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereof

Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof

Anti-VEGF-PD1 bispecific antibody with novel structure and use thereof

Anti-TREM-1 antibodies and uses thereof

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

ANTI-TIM-3 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-TIM-3 ANTIBODIES AND METHODS OF MAKING AND USING ANTI-TIM-3 ANTIBODIES

Anti-podoplanin antibody

ANTI-CLDN18.2 ANTIBODY AND USES THEREOF

Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

HUMANIZED AND VARIANT TGF-BETA1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

Antibodies binding to citrullinated histone 2A and/or 4

α-synuclein protofibril-binding antibodies

Pan-ebola virus neutralizing human antibodies and methods of use therefor

Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)

Anti-VLA-4 antibodies

Stable antibody-drug conjugate, preparation method therefor, and use thereof

T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY

Antibody against pan-species-specific plasmodium lactate dehydrogenase

ANTI-MERTK ANTIBODIES FOR TREATING CANCER

REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-FXIA ANTIBODIES

Antigen-binding constructs targeting HER2

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

Variant antibodies that bind OX40

Antibodies targeting CD137 and methods of use thereof

Antibodies, uses and methods

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

INTERFERON RECEPTOR 1 ANTIBODIES AND THEIR USES

Anti-Met fab-Fc for the treatment of a tumor and/or metastasis

Anti-B7-H3 monoclonal antibody and use thereof in cell therapy

Anti-Siglec-5 antibodies and methods of use thereof

HUMANIZED MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN-6, ENCODING GENES AND USES THEREOF

HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE

Anti-human NGF antibodies and methods using same

Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH

Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)

ANTIBODIES BINDING TO CITRULLINATED HISTONE 2A AND/OR 4

NS1-binding protein

STEREOTYPIC NEUTRALIZING VH CLONOTYPES AGAINST SARS-COV-2 RBD IN COVID-19 PATIENTS AND THE HEALTHY POPULATION

VARIANT NUCLEIC ACID LIBRARIES FOR CORONAVIRUS

STABLE PREPARATION COMPRISING ANTI-PCSK9 ANTIBODY

METHODS FOR TREATMENT USING CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CONJUGATE, SACITUZUMAB GOVITECAN (IMMU-132)

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

Procoagulant antibodies

Cyclic Single-Chain Antibody

Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same

Humanized anti-SIRPα antibodies

Anti-CD39 antibodies

Antigen Binding Proteins that Bind BCMA

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

ANTIGEN-BINDING MOLECULES CAPABLE OF BINDING CD3 AND CD137 BUT NOT SIMULTANEOUSLY

Anti-human CD89 antibodies and uses thereof

A MULTISPECIFIC ANTIBODY AND PREPARATION METHOD AND USE THEREOF

HUMANIZED AND VARIANT TGF-BETA3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

Antibodies and uses thereof

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

Anti-CfaE antibodies and methods of use

Compounds specific to coronavirus S protein and uses thereof

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

Novel Rationally Designed Protein Compositions

Rabbit antibodies to human immunoglobulins G

Anti-mesothelin binding proteins

Bispecific antibody which binds to CD40 and EpCAM

Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA

ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF

HUMAN ANTIBODIES TO PD-L1

Anti-PD-L1 antibodies

Anti-PD-1 antibodies

MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELLS AND USES THEREOF TO TREAT AUTOIMMUNE DISORDERS

Methods for achieving therapeutically effective doses of anti-CD47 agents

Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof

MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF

Anti-claudin 18.2 antibodies and uses thereof

Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same

IL-36 ANTIBODIES AND USES THEREOF

RGMC-selective inhibitors and use thereof

Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection

COMPOSITIONS FOR DISEASE TREATMENT

Antibodies to ticagrelor and methods of use

Low-viscosity antigen binding proteins and methods of making them

Thrombin-Binding Antibody Molecules And Uses Thereof

Modulators of ROR1-ROR2 binding

Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders

Anti PD-L1 antibodies

ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES

Anti-LAG-3 antibody and use thereof

HOMODIMERIC BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF

Anti-CD200R1 antibodies and methods of use thereof

LILRB4 antibodies and uses thereof

Anti-transthyretin antibodies

ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

Human antibodies to influenza hemagglutinin

Compositions and methods for the depletion of CD5+ cells

ANTI-RSPO3 ANTIBODIES AND METHODS OF USE

Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein

Antibodies against signal-regulatory protein alpha and methods of use

Antibodies That Bind CD39 and Uses Thereof

ANTI-4-1BB ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF

ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

SIGLEC NEUTRALIZING ANTIBODIES

Fusion proteins comprising extracellular domain of human CD22

CD226 agonist antibodies

Compositions and methods for modulating LAIR signal transduction

Anti-IL-33 antibodies and uses thereof

Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer

Antibodies directed against leukotoxins

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

Glypican 3 antibodies and conjugates thereof

Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof

NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

Compositions and Methods For Treating Cancer with Anti-Renalase antibodies and Anti-PD1 antibodies

Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use

Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)

IL3Ralpha antibodies and uses thereof

Anti-PD-1 antibodies

Anti-CD79 Antibodies and Their Uses

ILT-binding agents and methods of use thereof

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

Anti-IL-5 Antibodies

Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatment

Anti-tenascin C antibodies and uses thereof

Variant nucleic acid libraries for coronavirus

CONTORSBODY - A SINGLE CHAIN TARGET BINDER

Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

NOVEL ANTI-SIRPA ANTIBODIES

Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors

ANTIBODIES AGAINST TL1A AND USES THEREOF

Anti-Vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same

ROR2 antibody compositions and related methods

Engineered antibody Fc variants for enhanced serum half life

Anti-CD19 antibodies and uses therof

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

BLYS ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

USE OF ANTI-FAM19A5 ANTIBODIES

ANTI-SYNUCLEIN ANTIBODIES

Human zika virus antibodies and methods of use therefor

Nucleic acids encoding single domain antibodies to chikungunya virus

Antibodies for SARS-CoV-2 and uses thereof

Synthetic single domain antibody

Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use

DECOY POLYPEPTIDES

METHOD FOR AFFINITY PURIFICATION

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF

5T4 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF

Anti-Jagged1 antigen binding proteins

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

High affinity B7-H6 antibodies and antibody fragments

Affibody proteins specific for B7-H3 (CD276)

Gene Signatures for Determining ICOS Expression

PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa

Anti-polyubiquitin antibodies and methods of use

Recombinant antibody against human cardiac troponin I

Immuno-based botulinum toxin serotype A activity assays

CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF

Monoclonal antigen-binding proteins to intracellular oncogene products

Antigen-binding polypeptides directed against CD38

Anti-CD20 glycoantibodies and uses thereof

Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor

Tie2-binding agents and methods of use

NOVEL CANCER IMMUNOTHERAPY ANTIBODY COMPOSITIONS

Guided combinational therapeutic antibody

Anti-IL-25 antibodies and use thereof

Trispecific antibodies against IL-17A, IL-17F and other pro-inflammatory molecule

Methods for altering body composition by administering anti-pro/latent myostatin antibodies

Single domain binding molecule

Humanized anti-complement factor Bb antibodies

Anti-Tau antibodies and methods of use

STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE

Antigen binding proteins that bind PD-L1

ANTIBODY FRAMEWORKS FOR REDUCING AGGREGATION OF MULTISPECIFIC ANTIBODIES

Anti-CD137 antigen-binding molecule and utilization thereof

Treatment of autoimmune disorders with CD154 antibodies

Fusion protein comprising IDS and use thereof

CD131 binding proteins and uses thereof

MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE

ALK7 binding proteins and uses thereof

ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF

CLL1-TARGETING ANTIBODY AND APPLICATION THEREOF

ANTIBODY TARGETING CTLA-4 , PREPARATION METHOD THEREFOR AND USE THEREOF

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

CD33×CD3 BINDING PROTEINS FOR TREATING INFLAMMATORY CONDITIONS AND DISEASES

Antibodies to TIGIT

Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion

HEAVY CHAIN ONLY ANTIBODIES TO ANG-2

ANTIBODIES AND CONJUGATES THEREOF

GARP-TGF-BETA ANTIBODIES

Binding protein of NS1 protein

Compounds specific to coronavirus S protein and uses thereof

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Anti-VISTA antibodies and fragments

Methods and compositions relating to anti-biotin antibodies

Anti-5T4 antibodies and antibody-drug conjugates

Anti-CD117 antibodies and conjugates

Multispecific antibodies against CD40 and CD137

Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND METHODS OF USE

Antagonistic anti-tumor necrosis factor receptor superfamily antibodies

Anti-FLT3 antibodies and compositions

Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs

METHODS OF USING ANTI-TREM2 ANTIBODIES

Anti-CD33 antibodies and methods of use thereof

BI-SPECIFIC BINDING MOLECULES

Immunotoxin for treating cancer

Allergen-specific antibodies

Identifying human B cells expressing anti-allergen antibodies

Polypeptides

Antibody specific to alpha-toxin of and uses thereof

Anti-RSV monoclonal antibody formulation

Canine antibody libraries

MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE

Bispecific antibodies that bind to CD38 and CD3

Antibody binding to human HER2 and preparation method and use thereof

Antibodies to MUC16 and methods of use thereof

Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody

Mesothelin and CD137 binding molecules

ANTI HLA-G SPECIFIC ANTIBODIES

ANTIBODIES THAT BIND CD277 AND USES THEREOF

Antibody constructs for DLL3 and CD3

CONDITIONALLY ACTIVE PROTEINS WITH pH SELECTIVITY

Single-domain antibody binding to the G protein alpha

Anti-IL-17A antibodies and use thereof

Expression vector encoding antibody molecule which binds IL-17A and IL-17F

Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof

MULTISPECIFIC ANTIBODIES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY

Activin type 2 receptor binding proteins methods of making them

Anti-KLK5 antibodies and methods of use

COMPOSITION AND METHODS FOR ANTI-TNFR2 ANTIBODIES

Colony stimulating factor 1 receptor (CSF1R) antibodies and immunoconjugates thereof

Cysteine engineered fibronectin type III domain binding molecules

Humanized anti-human CTLA4 monoclonal antibody, preparation method therefor and use thereof

COMBINATION OF LILRB1/2 PATHWAY INHIBITORS AND PD-1 PATHWAY INHIBITORS

BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF

CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof

Proteins and Uses

Composition for prophylaxis or treatment of IL-8 related diseases

Isoform-selective anti-TGFβ antibodies and methods of use

COMBINATION THERAPY

NS1-Binding Protein and Uses Thereof

Anti-glycan antibodies and uses thereof

BISPECIFIC ANTIGEN BINDING MOLECULES WITH TRIVALENT BINDING TO CD40

MULTI-SPECIFIC WNT SURROGATE MOLECULES AND USES THEREOF

BINDING MOIETY FOR CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

ANTIBODIES

Bispecific antibodies targeting immune checkpoints

METHOD OF TREATING CANCER

ENGINERRED ANTIBODIES TO HIV ENV

Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant

Anti-BCMA antibody and use thereof

ANTIBODY CONSTRUCTS FOR CD70 AND CD3

Antigen binding molecules that bind light

Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibody

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

ANTI-CD74 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD74 ANTIBODIES AND METHODS OF USING ANTI-CD74 ANTIBODIES

Ranking system for immunogenic cancer-specific epitopes

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

Multispecific binding constructs against checkpoint molecules and uses thereof

Anti-PD-1 antibodies and uses thereof

ANTIBODIES SPECIFIC TO FOLATE RECEPTOR ALPHA

Anti-interleukin-33 antibodies and uses thereof